← Back to Clinical Trials
Recruiting NCT07802574

NCT07802574 Effects of Interrupting Prolonged Sitting With Different Standing Intervals on Vascular Health in Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07802574
Status Recruiting
Phase
Sponsor King Saud University
Condition Prolonged Sitting
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-04-02
Primary Completion 2026-09-20

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Short Standing IntervalContinuous Standing IntervalIntermittent Standing Interval

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2026-04-02 with a primary completion date of 2026-09-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to examine the effects of interrupting prolonged sitting with different standing intervals on vascular health in healthy women aged 18-45 years. The main questions it aims to answer are: Does interrupting prolonged sitting with short standing intervals (10 minutes every hour) improve blood pressure and pulse wave velocity more than prolonged continuous standing intervals (30 minutes every hour)? Does interrupting prolonged sitting with prolonged intermittent standing intervals (30 minutes every hour divided into three 10-minute standing bouts) improve blood pressure and pulse wave velocity more than prolonged continuous standing intervals (30 minutes every hour)? The researcher will compare three different sitting interruption conditions to evaluate their effects on vascular health outcomes: Standing for 10 minutes every hour. Continuous standing for 30 minutes every hour. Intermittent standing for 30 minutes every hour divided into three 10-minute standing bouts. Participants will: Attend three experimental sessions in random order separated by at least 7 days. Complete 3 hours of sitting with different standing interruption protocols. Undergo measurements of blood pressure, pulse wave velocity, and heart rate before sitting and after each hour of the experiment. Undergo height, weight, and body mass index measurements.

Eligibility Criteria

Inclusion Criteria: Female participants aged 18-45 years. Healthy individuals with normal blood pressure levels (systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg). Body mass index (BMI) less than 30 kg/m². Ability to stand without support. No history of cardiovascular disease or chronic diseases that may affect study outcomes. Exclusion Criteria: Pregnancy or breastfeeding. Back injuries preventing prolonged sitting. Use of medications that may affect cardiovascular responses, including antihypertensive, antidiabetic, antidepressant, or hormonal medications. Presence of chronic diseases or cardiovascular conditions affecting vascular health. \-

Contact & Investigator

Central Contact

Bushra k Alharbi

✉ bu1.kh2@gmail.com

📞 +966556913301

Principal Investigator

Abdullah B Alansare, PhD

STUDY CHAIR

King Saud University

Frequently Asked Questions

Who can join the NCT07802574 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Prolonged Sitting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07802574 currently recruiting?

Yes, NCT07802574 is actively recruiting participants. Contact the research team at bu1.kh2@gmail.com for enrollment information.

Where is the NCT07802574 trial being conducted?

This trial is being conducted at Riyadh, Saudi Arabia.

Who is sponsoring the NCT07802574 clinical trial?

NCT07802574 is sponsored by King Saud University. The principal investigator is Abdullah B Alansare, PhD at King Saud University. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology